Immunogenic cell death

被引：195

作者：

Garg, Abhishek D. ^{[1
]}

Dudek-Peric, Aleksandra M. ^{[1
]}

Romano, Erminia ^{[1
]}

Agostinis, Patrizia ^{[1
]}

机构：

[1] Univ Leuven, KULeuven, Dept Cellular & Mol Med, Cell Death Res & Therapy CDRT Lab, Leuven, Belgium

来源：

INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY | 2015年 / 59卷 / 1-3期

关键词：

immunogenicity; immunogenic cell death; cancer; danger signals; antigen; damage-associated molecular patterns; danger signalling; ER stress; photodynamic therapy (PDT); chemotherapy; ANTICANCER IMMUNE-RESPONSES; HUMAN TUMOR-CELLS; CALRETICULIN EXPOSURE; T-CELLS; APOPTOTIC CELLS; CANCER-THERAPY; URIC-ACID; ER STRESS; SECRETORY PATHWAY; SURFACE EXPOSURE;

D O I：

10.1387/ijdb.150061pa

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Currently, it is widely acknowledged that a proactive anticancer immunosurveillance mechanism takes part in the rejection of neoplastic lesions before they progress towards a benign or malignant tumour. However in cases of very aggressive neoplastic lesions consisting of cells with high mutational diversity, cancer cell variants might be formed that are capable of evading host defence systems against uncontrolled proliferation and anticancer immunosurveillance. This is mainly accomplished through the exhibition of low immunogenicity, which is a particularly important stumbling block in the revival of long-lasting as well as stable anticancer immunity. Recently, it has emerged emphatically that inciting a cancer cell death routine, associated with the activation of danger signalling pathways evoking emission of damage-associated molecular patterns (DAMPs), markedly increases the immunogenicity of dying cancer cells. This cell death pathway has been termed "immunogenic cell death" (ICD). In the present review we introduce this concept and discuss its characteristics in detail. We also discuss in detail the various molecular, immunological and operational determinants of ICD.

引用

页码：131 / 140

页数：10

共 94 条

[1] Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy [J].

Adkins, Irena ;

Fucikova, Jitka ;

Garg, Abhishek D. ;

Agostinis, Patrizia ;

Spisek, Radek .

ONCOIMMUNOLOGY, 2014, 3 (12) :1-12

[2] The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy [J].

Apetoh, Lionel ;

Ghiringhelli, Francois ;

Tesniere, Antoine ;

Criollo, Alfredo ;

Ortiz, Carla ;

Lidereau, Rosette ;

Mariette, Christophe ;

Chaput, Nathalie ;

Mira, Jean-Paul ;

Delaloge, Suzette ;

Andre, Fabrice ;

Tursz, Thomas ;

Kroemer, Guido ;

Zitvogel, Laurence .

IMMUNOLOGICAL REVIEWS, 2007, 220 :47-59

[3] Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy [J].

Apetoh, Lionel ;

Ghiringhelli, Francois ;

Tesniere, Antoine ;

Obeid, Michel ;

Ortiz, Carla ;

Criollo, Alfredo ;

Mignot, Gregoire ;

Maiuri, M. Chiara ;

Ullrich, Evelyn ;

Saulnier, Patrick ;

Yang, Huan ;

Amigorena, Sebastian ;

Ryffel, Bernard ;

Barrat, Franck J. ;

Saftig, Paul ;

Levi, Francis ;

Lidereau, Rosette ;

Nogues, Catherine ;

Mira, Jean-Paul ;

Chompret, Agnes ;

Joulin, Virginie ;

Clavel-Chapelon, Francoise ;

Bourhis, Jean ;

Andre, Fabrice ;

Delaloge, Suzette ;

Tursz, Thomas ;

Kroemer, Guido ;

Zitvogel, Laurence .

NATURE MEDICINE, 2007, 13 (09) :1050-1059

[4] The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity [J].

Behrens, Marshall D. ;

Wagner, Wolfgang M. ;

Krco, Christopher J. ;

Erskine, Courtney L. ;

Kalli, Kimberly R. ;

Krempski, James ;

Gad, Ekram A. ;

Disis, Mary L. ;

Knutson, Keith L. .

BLOOD, 2008, 111 (03) :1472-1479

[5] REJECTION BY SYNGENEIC MICE OF CELL VARIANTS OBTAINED BY MUTAGENESIS OF A MALIGNANT TERATOCARCINOMA CELL LINE [J].

BOON, T ;

KELLERMANN, O .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (01) :272-275

[6] TERATOCARCINOMA CELL VARIANTS REJECTED BY SYNGENEIC MICE - PROTECTION OF MICE IMMUNIZED WITH THESE VARIANTS AGAINST OTHER VARIANTS AND AGAINST ORIGINAL MALIGNANT CELL LINE [J].

BOON, T ;

VANPEL, A .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (03) :1519-1523

[7] Bleomycin Exerts Ambivalent Antitumor Immune Effect by Triggering Both Immunogenic Cell Death and Proliferation of Regulatory T Cells [J].

Bugaut, Helene ;

Bruchard, Melanie ;

Berger, Helene ;

Derangere, Valentin ;

Odoul, Ludivine ;

Euvrard, Romain ;

Ladoire, Sylvain ;

Chalmin, Fanny ;

Vegran, Frederique ;

Rebe, Cedric ;

Apetoh, Lionel ;

Ghiringhelli, Francois ;

Mignot, Gregoire .

PLOS ONE, 2013, 8 (06)

[8] Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death [J].

Casares, N ;

Pequignot, MO ;

Tesniere, A ;

Ghiringhelli, F ;

Roux, S ;

Chaput, N ;

Schmitt, E ;

Hamai, A ;

Hervas-Stubbs, S ;

Obeid, M ;

Coutant, F ;

Métivier, D ;

Pichard, E ;

Aucouturier, P ;

Pierron, G ;

Garrido, C ;

Zitvogel, L ;

Kroemer, G .

JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (12) :1691-1701

[9] Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory [J].

Chang, MK ;

Binder, CJ ;

Miller, YI ;

Subbanagounder, G ;

Silverman, GJ ;

Berliner, JA ;

Witztum, JL .

JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (11) :1359-1370

[10] Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47 [J].

Chao, Mark P. ;

Jaiswal, Siddhartha ;

Weissman-Tsukamoto, Rachel ;

Alizadeh, Ash A. ;

Gentles, Andrew J. ;

Volkmer, Jens ;

Weiskopf, Kipp ;

Willingham, Stephen B. ;

Raveh, Tal ;

Park, Christopher Y. ;

Majeti, Ravindra ;

Weissman, Irving L. .

SCIENCE TRANSLATIONAL MEDICINE, 2010, 2 (63)

← 1 2 3 4 5 6 7 8 9 10 →